China A50 Index (Intraday) Rallied After Trump's Speech and PMI Data

In response to China imposing a controversial national security law on Hong Kong, U.S. President Donald Trump announced that preferential trade treatment for Hong Kong would be ended.....

China

In response to China imposing a controversial national security law on Hong Kong, U.S. President Donald Trump announced that preferential trade treatment for Hong Kong would be ended. He also said sanctions would be imposed on Chinese and Hong Kong officials involved in eroding the city's autonomy. However, after Trump's speech, U.S.'s S&P index returned to positive territory and closed higher with a 0.5% gain. The price reaction would mean that Trump's speech is in line with the market's expectation.

On the economic front, China's official Manufacturing PMI fell to 50.6 in May (51.1 expected) from 50.8 in April, while Non-manufacturing PMI climbed to 53.6 (53.5 expected) from 53.2. Meanwhile, Caixin China Manufacturing PMI rose to 50.7 in May (49.6 expected) from 49.4 in April. Above data shows that China's economic activities returned to moderate expansion as all PMI data are above 50. Investors would expect the continuation of economic recovery after the outbreak of COVID-19.

On the 1-hour chart, the index jumped and broke above the declining trend line drawn from March top. Besides, the prices stand above the 61.8% retracement level. Both signals would suggest that the correction wave from March top is possibly ended.

Bullish readers could set the support level at 13410 (the previous high) and resistance levels at 13700 (the March top) and 13890 (127.2% retracement level).


Sources: GAIN Capital, TradingView.

More from A50

From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.